Circular RNA Eps15-homology domain containing protein 2 motivates proliferation, glycolysis but refrains autophagy in non-small cell lung cancer via crosstalk with microRNA-3186-3p and forkhead box K1

References

• Johnson AM, Hines RB, Johnson JA 3rd, et al. Treatment and survival disparities in lung cancer: the effect of social environment and place of residence. Lung Cancer. 2014;83:401–407.
   PubMed Web of Science ®Google Scholar
• Smith CB, Bonomi M, Packer S, et al. Disparities in lung cancer stage, treatment and survival among American Indians and Alaskan Natives. Lung Cancer. 2011;72:160–164.
   PubMed Web of Science ®Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.
   PubMed Web of Science ®Google Scholar
• Shi Y, Sun Y, Ding C, et al. [China experts consensus on icotinib for non-small cell lung cancer treatment(2016 version)]. Zhongguo Fei Ai Za Zhi. 2016;19:489–494.
   PubMedGoogle Scholar
• Chen LL, Yang L. Regulation of circRNA biogenesis. RNA Biol. 2015;12:381–388.
   PubMed Web of Science ®Google Scholar
• Zhang C-C, Li Y, Feng X-Z, et al. Circular RNA circ_0001287 inhibits the proliferation, metastasis, and radiosensitivity of non-small cell lung cancer cells by sponging microRNA miR-21 and up-regulating phosphatase and tensin homolog expression.[J]. Bioengineered. 2021;12:414–425.
   PubMed Web of Science ®Google Scholar
• Yunting Z, Shaolin Z, Tao W. Circular RNA hsa_circ_0002360 promotes non-small cell lung cancer progression through upregulating matrix metalloproteinase 16 and sponging multiple micorRNAs.[J], Bioengineered, 2021; undefined: undefined
   Web of Science ®Google Scholar
• Wang Y, Zang RK, Du YN. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway. J Biol Regul Homeost Agents. 2020;34:2037–2047.
   PubMed Web of Science ®Google Scholar
• Geng QQ, Wu QF, Zhang Y, et al. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC. Eur Rev Med Pharmacol Sci. 2020;24:9473–9479.
   PubMed Web of Science ®Google Scholar
• Frey L, Klümper N, and Schmidt D, et al. CircEHD2, CircNETO2 and CircEGLN3 as diagnostic and prognostic biomarkers for patients with renal cell carcinoma. Cancers (Basel). 2021;13(9):2177.
   Web of Science ®Google Scholar
• Zhou J, Wang L, Sun Q, et al. Hsa_circ_0001666 suppresses the progression of colorectal cancer through the miR-576-5p/PCDH10 axis.[J]. Clin Transl Med. 2021;11:e565.
   PubMed Web of Science ®Google Scholar
• Zhijing R, Qinqin Y, Jiajia G, et al. Circular RNA hsa_circ_0000073 enhances osteosarcoma cells malignant behavior by sponging miR-1252-5p and modulating CCNE2 and MDM2.[J]. Front Cell Dev Biol. 2021;9:714601.
   PubMed Web of Science ®Google Scholar
• Zhang D, Zhang G, Yu K, et al. Circ_0003204 knockdown protects endothelial cells against oxidized low-density lipoprotein-induced injuries by targeting the miR-491-5p-ICAM1 pathway.[J]. J Thromb Thrombolysis. 2021. undefined: undefined.
   Web of Science ®Google Scholar
• Fan X, Yin X, Zhao Q, et al. Hsa_circRNA_0045861 promotes renal injury in ureteropelvic junction obstruction via the microRNA-181d-5p/sirtuin 1 signaling axis.[J]. Ann Transl Med. 2021;9:1571.
   PubMed Web of Science ®Google Scholar
• Liu M, Wang P, Sui X, et al. Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR-3186-3p/TNRC6B axis. J Cell Biochem. 2020;121:4226–4238.
   PubMed Web of Science ®Google Scholar
• Niu J, Wang Y, Hu Y, et al. Mechanisms of miR-195-5p and FOXK1 in rat xenograft models of non-small cell lung cancer. Am J Transl Res. 2021;13:2528–2536.
   PubMed Web of Science ®Google Scholar
• Li B, Zhu L, Lu C, et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity.[J]. Nat Commun. 2021;12:295.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ma C, Lv A, et al. Circular RNA circ_0010235 sponges miR-338-3p to play oncogenic role in proliferation, migration and invasion of non-small-cell lung cancer cells through modulating KIF2A. Ann Med. 2021;53:693–706.
   PubMed Web of Science ®Google Scholar
• Yang B, Zhao F, Yao L, et al. CircRNA circ_0006677 inhibits the progression and glycolysis in non-small-cell lung cancer by sponging miR-578 and regulating SOCS2 expression. Front Pharmacol. 2021;12:657053.
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Kimmelman AC, Debnath J. Targeting autophagy in cancer: recent advances and future directions. Cancer Discov. 2019;9:1167–1181.
   PubMed Web of Science ®Google Scholar
• Ganapathy-Kanniappan S, Geschwind JF. Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer. 2013;12:152.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chen P, Gao H, et al. Ubiquitylation of autophagy receptor optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell. 2014;26:106–120.
   PubMed Web of Science ®Google Scholar
• Zheng S, Yang L, Zou Y, et al. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer. J Hematol Oncol. 2020;13:17.
   PubMed Web of Science ®Google Scholar
• Cui H, Gao Q, Zhang L, et al. Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis. Life Sci. 2018;213:66–73.
   PubMed Web of Science ®Google Scholar
• Sun H, Wang H, Wang X, et al. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics. 2020;10:6928–6945.
   PubMed Web of Science ®Google Scholar
• Wang Y, Sun L, Qiu W, et al. Inhibiting forkhead box K1 induces autophagy to reverse epithelial-mesenchymal transition and metastasis in gastric cancer by regulating Myc-associated zinc finger protein in an acidic microenvironment. Aging (Albany NY). 2020;12:6129–6150.
   PubMedGoogle Scholar
• Frey L, Klümper N, Schmidt D, et al. CircEHD2, CircNETO2 and CircEGLN3 as diagnostic and prognostic biomarkers for patients with renal cell carcinoma.[J]. Cancers (Basel). 2021;13. undefined.
   Web of Science ®Google Scholar